Gyre Therapeutics, Inc. (GYRE)
7.865
-0.60
(-7.03%)
USD |
NASDAQ |
Dec 11, 16:00
7.865
0.00 (0.00%)
After-Hours: 20:00
Gyre Therapeutics EPS Diluted (Quarterly): 0.0349 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ADMA Biologics, Inc. | 0.1489 |
| Savara, Inc. | -0.1366 |
| Exelixis, Inc. | 0.695 |
| Vanda Pharmaceuticals, Inc. | -0.3822 |
| Aldeyra Therapeutics, Inc. | -0.1279 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 5.936M |
| Revenue (Quarterly) | 30.56M |
| Total Expenses (Quarterly) | 26.95M |
| Enterprise Value | 791.59M |
| Gross Profit Margin (Quarterly) | 94.67% |
| Profit Margin (Quarterly) | 19.42% |
| Earnings Yield | 0.48% |
| Operating Earnings Yield | 1.55% |
| Normalized Earnings Yield | 0.2517 |